A retrospective analysis of advanced thyroid cancer patients also showed that MTKIs reduce calcium levels through both PTH-dependent and PTH-independent mechanisms, suggesting their efficacy in correcting hypercalcemia in PC (28). The gene discussed is PTH; the disease is Hypercalcemia.